Dosing is Complete in Lexaria's Second GLP-1 Human Pilot Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/29/2026

1. V
2. KLAC
3. PYPL
4. BE
5. SWKS
6. F
7. STX
8. CSGP
9. VRNS
10. NXPI

Go back to Dosing is Complete in Lexaria's Second GLP-1 Human Pilot Study
(NASDAQ: LEXX) Delayed: 0.55 +0.01 (1.85%)
Previous Close $0.54    52 Week High $ 
Open $0.54    52 Week Low $ 
Day High $0.55    P/E N/A 
Day Low $0.54    EPS $ 
Volume 2,139